Holocene Advisors LP Has $4.13 Million Stake in Ingevity Co. (NYSE:NGVT)

Holocene Advisors LP lifted its position in shares of Ingevity Co. (NYSE:NGVT) by 274.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 54,696 shares of the company’s stock after acquiring an additional 40,075 shares during the quarter. Holocene Advisors LP owned approximately 0.14% of Ingevity worth $4,131,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in NGVT. Renaissance Technologies LLC boosted its holdings in shares of Ingevity by 1,278.0% during the 4th quarter. Renaissance Technologies LLC now owns 68,900 shares of the company’s stock valued at $5,218,000 after acquiring an additional 63,900 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in Ingevity by 3,200,000.0% during the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 32,001 shares of the company’s stock worth $2,423,000 after buying an additional 32,000 shares during the period. Credit Suisse AG lifted its holdings in Ingevity by 63.8% during the 4th quarter. Credit Suisse AG now owns 57,585 shares of the company’s stock worth $4,361,000 after buying an additional 22,440 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in Ingevity by 2.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 336,597 shares of the company’s stock worth $25,491,000 after buying an additional 6,642 shares during the period. Finally, Guggenheim Capital LLC lifted its holdings in Ingevity by 24.7% during the 4th quarter. Guggenheim Capital LLC now owns 6,052 shares of the company’s stock worth $458,000 after buying an additional 1,199 shares during the period. 90.58% of the stock is currently owned by institutional investors.

NGVT stock opened at $78.41 on Thursday. Ingevity Co. has a 1-year low of $47.11 and a 1-year high of $89.55. The company has a market cap of $3.14 billion, a price-to-earnings ratio of 15.55 and a beta of 2.22. The stock has a 50-day simple moving average of $82.53. The company has a debt-to-equity ratio of 1.91, a quick ratio of 1.95 and a current ratio of 2.86.

Ingevity (NYSE:NGVT) last issued its earnings results on Wednesday, April 28th. The company reported $1.27 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.24. Ingevity had a return on equity of 33.94% and a net margin of 15.19%. The business had revenue of $320.30 million during the quarter, compared to analyst estimates of $293.05 million. During the same period in the previous year, the company posted $1.12 EPS. The firm’s revenue was up 11.1% compared to the same quarter last year. On average, equities analysts forecast that Ingevity Co. will post 5.32 earnings per share for the current year.

NGVT has been the topic of several recent research reports. Zacks Investment Research downgraded Ingevity from a “buy” rating to a “hold” rating and set a $86.00 target price on the stock. in a report on Friday, July 2nd. TheStreet raised Ingevity from a “c+” rating to a “b” rating in a report on Thursday, May 27th. BMO Capital Markets reissued a “buy” rating and issued a $112.00 price objective on shares of Ingevity in a research report on Friday, July 9th. Finally, Loop Capital lifted their price objective on Ingevity from $71.00 to $85.00 and gave the stock a “hold” rating in a research report on Thursday, May 27th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Ingevity has a consensus rating of “Buy” and a consensus target price of $82.00.

In related news, EVP Stuart Edward Jr. Woodcock sold 5,178 shares of the business’s stock in a transaction dated Friday, May 7th. The stock was sold at an average price of $85.76, for a total value of $444,065.28. Following the completion of the sale, the executive vice president now directly owns 30,516 shares of the company’s stock, valued at approximately $2,617,052.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.56% of the company’s stock.

Ingevity Company Profile

Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia-Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats.

See Also: What does a dividend yield signify to investors?

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Co. (NYSE:NGVT).

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.